Retinopathy

P. Scanlon
{"title":"Retinopathy","authors":"P. Scanlon","doi":"10.1093/med/9780198870197.003.0276","DOIUrl":null,"url":null,"abstract":"Diabetic retinopathy is the leading cause of blindness in the working age population of most developed countries but has been shown to no longer be the leading cause in England and Wales. The introduction of the national screening programmes has been considered to be a major contributor to this achievement. The people with diabetes who still lose vision are often non-attenders who present late in the disease when treatment is more difficult. Tightening of control of glycaemia and blood pressure can slow the disease progression. When sight threatening retinopathy is detected, laser treatment and vascular endothelial growth factor (VEGF) inhibitor treatments reduce the risk of visual loss. When advanced retinopathy is detected, vitrectomy results have improved considerably over the last 20 years and a reasonable level of vision is often retained.","PeriodicalId":130301,"journal":{"name":"Oxford Textbook of Endocrinology and Diabetes 3e","volume":"62 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oxford Textbook of Endocrinology and Diabetes 3e","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/med/9780198870197.003.0276","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Diabetic retinopathy is the leading cause of blindness in the working age population of most developed countries but has been shown to no longer be the leading cause in England and Wales. The introduction of the national screening programmes has been considered to be a major contributor to this achievement. The people with diabetes who still lose vision are often non-attenders who present late in the disease when treatment is more difficult. Tightening of control of glycaemia and blood pressure can slow the disease progression. When sight threatening retinopathy is detected, laser treatment and vascular endothelial growth factor (VEGF) inhibitor treatments reduce the risk of visual loss. When advanced retinopathy is detected, vitrectomy results have improved considerably over the last 20 years and a reasonable level of vision is often retained.
视网膜病变
糖尿病视网膜病变是大多数发达国家工作年龄人口失明的主要原因,但在英格兰和威尔士已不再是主要原因。国家筛查方案的推行被认为是取得这一成就的一个主要因素。仍然失明的糖尿病患者往往不参加治疗,他们出现的时间较晚,这时治疗比较困难。加强对血糖和血压的控制可以减缓疾病的进展。当发现威胁视力的视网膜病变时,激光治疗和血管内皮生长因子(VEGF)抑制剂治疗可降低视力丧失的风险。在过去的20年里,当发现晚期视网膜病变时,玻璃体切除术的结果有了很大的改善,并且通常保留了合理的视力水平。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信